Replimune (REPL) Deferred Taxes (2017 - 2019)
Replimune (REPL) posted Deferred Taxes of -$144000.0 for Q1 2019, down 209.09% sequentially from $132000.0 in Q4 2018, and down 1957.14% YoY from $7753.8 in Q1 2018.
Analysis
Replimune (REPL) Deferred Taxes (2017 - 2019) Analysis & Trends
Replimune has reported Deferred Taxes for 3 years, with the latest figure at -$144000.0 in Q1 2019.
- Quarterly Deferred Taxes fell 1957.14% year-over-year to -$144000.0 in Q1 2019, while the trailing twelve-month figure through Mar 2019 was -$24000.0 (up 4.0% YoY) and the FY2019 annual result came in at -$24000.0, up 4.0% from the prior year.
- Deferred Taxes eased to -$144000.0 in Q1 2019 per REPL's latest filing, from $132000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $132000.0 in Q4 2018 and troughed at -$144000.0 in Q1 2019.
- A 3-year average of -$6125.0 and a median of -$6000.0 in 2017 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2018 and 2019: Deferred Taxes surged 2300.0% in 2018, then plunged 1957.14% in 2019.
- Over 3 years, Deferred Taxes stood at -$6000.0 in 2017, then soared by 2300.0% to $132000.0 in 2018, then sank by 209.09% to -$144000.0 in 2019.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$144000.0, $132000.0, and -$6000.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Replimune | 1.46 Bn | 1.46 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -144,000.00 |
| Dec 31, 2018 | 132,000.00 |
| Sep 30, 2018 | -6,000.00 |
| Jun 30, 2018 | -6,000.00 |
| Mar 31, 2018 | -7,000.00 |
| Dec 31, 2017 | -6,000.00 |
| Sep 30, 2017 | -6,000.00 |
| Jun 30, 2017 | -6,000.00 |